Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on MorphoSys AG patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
CN115054697A | Application | 抗-CD19抗体和磷酸肌醇3-激酶抑制剂的组合及其用途 | A61K2300/00; A61K31/505; A61K31/519; A61K39/395; A61K39/39558; A61P35/02; C07D403/12; C07D473/16; C07K16/2803; C07K2317/565; C07K2317/73 | September 16, 2022 |
WO2022184676A1 | Application | ANTI-CD38 ANTIBODIES FOR USE IN THE TREATMENT OF ANTIBODY-MEDIATED TRANSPLANT REJECTION | A61K2039/505; A61K2039/545; A61P37/06; C07K16/2896; C07K2317/21 | September 09, 2022 |
CN115028617A | Application | CBP/EP300的杂环抑制剂及其在治疗癌症中的用途 | A61K31/435; A61K31/437; A61K31/4375; A61K31/496; A61K31/4985; A61K31/5025; A61K31/519; A61K31/5377; A61K31/5513; A61K45/06; A61P29/00; A61P35/00; A61P35/02; A61P37/06; C07D243/14; C07D267/14; C07D401/14; C07D405/14; C07D409/14; C07D413/04; C07D413/10; C07D413/14; C07D417/14; C07D471/04; C07D487/04; C07D487/22 | September 09, 2022 |
US20220283166A1 | Application | METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS | A61P35/02; A61P35/04; C07K16/2896; G01N2333/70535; G01N2800/52; G01N33/57426; G01N33/57492 | September 08, 2022 |
EP4051710A1 | Application | ANTI-TUMOR-KOMBINATIONSTHERAPIE MIT ANTI-CD19-ANTIKÖRPERN UND GAMMA-DELTA-T-ZELLEN | A61K2039/505; A61K2300/00; A61K35/17; A61K39/395; A61P35/02; C07K16/2803; C07K2317/565; C07K2317/732 | September 07, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer